 | Neoleukin Therapeutics (NASDAQ:NLTX) Shares Gap Down to $11.97 americanbankingnews.com - April 12 at 11:30 AM |
 | Neoleukin Therapeutics' (NLTX) "Buy" Rating Reiterated at Mizuho americanbankingnews.com - April 12 at 12:46 AM |
 | Carl Walkey Sells 1,800 Shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Stock americanbankingnews.com - April 8 at 7:50 PM |
 | Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Expected to Post Earnings of -$0.24 Per Share americanbankingnews.com - April 6 at 10:18 PM |
 | Neoleukin Therapeutics (NASDAQ:NLTX) Trading Down 4.3% americanbankingnews.com - April 6 at 1:02 PM |
 | Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) SVP Sells $21,528.00 in Stock americanbankingnews.com - April 2 at 7:52 PM |
 | Head-To-Head Comparison: Neoleukin Therapeutics (NASDAQ:NLTX) and Milestone Pharmaceuticals (NASDAQ:MIST) americanbankingnews.com - March 31 at 8:44 AM |
 | Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) to Post Q1 2022 Earnings of ($0.35) Per Share, Piper Sandler Forecasts americanbankingnews.com - March 31 at 3:12 AM |
 | Research Analysts Set Expectations for Neoleukin Therapeutics, Inc.'s Q1 2022 Earnings (NASDAQ:NLTX) americanbankingnews.com - March 29 at 2:34 AM |
 | Neoleukin Therapeutics, Inc.'s (NLTX) CEO Jonathan Drachman on Q4 2020 Results - Earnings Call Transcript seekingalpha.com - March 27 at 3:45 AM |
|
 | Neoleukin Therapeutics (NASDAQ:NLTX) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS americanbankingnews.com - March 26 at 11:48 AM |
 | Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Receives Consensus Recommendation of "Buy" from Analysts americanbankingnews.com - March 26 at 2:40 AM |
 | Neoleukin Therapeutics Announces Year End 2020 Financial Results finance.yahoo.com - March 25 at 8:47 PM |
 | Brokerages Anticipate Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) to Announce -$0.21 EPS americanbankingnews.com - March 20 at 4:10 PM |
 | Neoleukin Therapeutics to Host 2020 Financial Results Conference Call and Webcast on March 25, 2021 finance.yahoo.com - March 18 at 12:11 PM |
 | Neoleukin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference finance.yahoo.com - March 2 at 10:44 AM |
 | Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days finance.yahoo.com - February 5 at 10:46 AM |
 | Neoleukin Therapeutics: De Novo Protein Design Platform seekingalpha.com - February 5 at 5:46 AM |
 | SHAREHOLDER ALERT: Investigation of Neoleukin Therapeutics Announced by Holzer & Holzer, LLC finance.yahoo.com - January 25 at 5:29 PM |
 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neoleukin Therapeutics, Inc. - NLTX finance.yahoo.com - January 24 at 6:18 AM |
 | Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Neoleukin Therapeutics, Inc. (NLTX) Investigation finance.yahoo.com - January 14 at 7:14 PM |
 | Neoleukin Gets FDA Clinical Hold Letter Related To IND Of NL-201 - Quick Facts nasdaq.com - January 8 at 12:53 PM |
 | Why Neoleukin Therapeutics Stock Is Down Today fool.com - January 8 at 12:53 PM |
 | Neoleukin Therapeutics Receives Clinical Hold Letter from U.S. FDA Related to CMC Assay Development for NL-201 finance.yahoo.com - January 8 at 12:53 PM |
 | U.S. FDA puts early-stage trial of Neoleukin potential cancer treatment on hold finance.yahoo.com - January 8 at 12:53 PM |
 | Neoleukin Therapeutics to Present at J.P. Morgan Healthcare Conference finance.yahoo.com - January 7 at 11:35 AM |
 | Neoleukin Therapeutics, Inc. fool.com - December 24 at 10:36 PM |
 | Neoleukin: New Phase 1 Initiation, Strong Managerial Expertise, And Promising Technology seekingalpha.com - December 18 at 1:28 PM |
 | Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer finance.yahoo.com - December 10 at 9:22 AM |
 | Neoleukin Therapeutics Inc. barrons.com - November 27 at 12:31 AM |
|
 | Neoleukin Therapeutics Announces Participation in Piper Sandler 32nd Annual Virtual Healthcare Conference finance.yahoo.com - November 23 at 8:21 AM |
 | How One Company Pivoted From Cancer To Coronavirus And Designed A Virus-Blocking Drug In 10 Weeks forbes.com - November 19 at 1:12 PM |
 | Did Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Insiders Buy Up More Shares? finance.yahoo.com - November 18 at 9:48 AM |
 | Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference finance.yahoo.com - November 11 at 12:30 PM |
 | Neoleukin Therapeutics Presents Preclinical Combination Data for NL-201 at Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020) finance.yahoo.com - November 10 at 12:32 PM |
 | Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update finance.yahoo.com - November 9 at 9:53 AM |
 | Neoleukin Therapeutics Announces Publication in Science of De Novo Protein Decoys that Block COVID-19 Infection In Vitro and Protect Animals In Vivo finance.yahoo.com - November 5 at 3:21 PM |
 | Neoleukin Therapeutics Appoints Holly K. Vance as General Counsel finance.yahoo.com - October 20 at 8:21 AM |
 | NEOLEUKIN TERAP. -,000001 (6AP.MU) au.finance.yahoo.com - October 14 at 4:43 AM |
 | Neoleukin Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference finance.yahoo.com - September 9 at 8:58 AM |
 | What Type Of Shareholders Own The Most Number of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Shares? finance.yahoo.com - August 20 at 3:12 PM |
 | Neoleukin (NLTX) Upgraded to Buy: What Does It Mean for the Stock? finance.yahoo.com - August 19 at 1:14 PM |
 | Neoleukin Therapeutics (NLTX) Investor Presentation - Slideshow seekingalpha.com - August 16 at 4:28 PM |
 | Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2020 Results - Earnings Call Transcript seekingalpha.com - August 12 at 11:11 PM |
 | Neoleukin Therapeutics Announces Second Quarter 2020 Financial Results & Provides Corporate Update finance.yahoo.com - August 12 at 6:11 PM |
 | Neoleukin Therapeutics to Present at Canaccord Genuity 40th Annual Growth Conference finance.yahoo.com - August 6 at 9:27 AM |
 | Neoleukin Therapeutics to Host Second Quarter 2020 Financial Results & Corporate Update Conference Call and Webcast on August 12, 2020 finance.yahoo.com - August 5 at 12:59 PM |
 | Were Hedge Funds Right About Neoleukin Therapeutics, Inc. (NLTX)? finance.yahoo.com - August 3 at 1:36 PM |
 | Is Neoleukin Therapeutics a Buy? finance.yahoo.com - July 15 at 8:34 AM |
 | Neoleukin (NLTX) Moves to Buy: Rationale Behind the Upgrade finance.yahoo.com - July 3 at 2:27 PM |